Adverum Biotechnologies Inc (NASDAQ:ADVM)
| 1.59 Delayed Data As of Jan 19 |  +0.05 / +3.25%Today’s Change | 1.54 Today|||52-Week Range 14.79 | -9.66% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Scopa James Paul Director |  Sale | 11/15/2021 | 50,000 | $2.18 | $109.0K | -26.73% |
Machado Clarence Patrick Director |  Buy | 3/24/2021 | 10,000 | $9.92 | $99.2K | -82.82% |
Fischer Laurent | Buy | 3/24/2021 | 10,000 | $9.88 | $98.8K | -82.82% |
Soparkar Peter N/A | Buy | 12/08/2021 | 25,000 | $1.91 | $47.8K | -14.97% |
Fischer Laurent | Buy | 12/09/2021 | 14,323 | $1.85 | $26.5K | -13.59% |
Fischer Laurent | Buy | 12/08/2021 | 10,677 | $1.79 | $19.1K | -14.97% |
Clark Julie /adverum/ Chief Medical Officer | Sale | 9/30/2021 | 4,766 | $2.17 | $10.3K | -26.73% |
Fischer Laurent | Gift | 8/06/2021 | 680,000 | $0.00 | $0.00 | -35.89% |
Soparkar Peter N/A | Gift | 8/06/2021 | 220,000 | $0.00 | $0.00 | -35.89% |
Thedinga Angela Chief Technology Officer | Gift | 8/06/2021 | 150,000 | $0.00 | $0.00 | -35.89% |
Page of 2